Cotton rat tumor model for the evaluation of oncolytic adenoviruses
- PMID: 15703497
- DOI: 10.1089/hum.2005.16.139
Cotton rat tumor model for the evaluation of oncolytic adenoviruses
Abstract
Oncolytic human adenovirus (Ad) vectors exert their antitumor effect by replicating in and lysing tumor cells. These vectors are commonly evaluated in immunodeficient mice bearing human tumor xenografts. However, this model suffers because the mice are immunodeficient and are not permissive for human Ads. We have developed a cotton rat model to test the selectivity, immunogenicity, and efficacy of oncolytic Ad vectors. The cotton rat is a rodent species that is semipermissive for human Ads. We show that the cotton cancer rat cell line LCRT supports the replication of human Ad in tissue culture and that the cells are destroyed on virus replication. When injected subcutaneously, LCRT cells formed tumors in immunocompetent cotton rats, and the growth of these tumors was delayed by the injection of an oncolytic Ad vector. Replication of the Ad vector in the tumor was demonstrated by sampling tumor tissue and isolating infectious virus particles at various times after intratumoral injection of the virus. We propose that the cotton rat can be used as an animal model to evaluate oncolytic Ad vectors.
Similar articles
-
Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus.Virology. 2007 Dec 5;369(1):131-42. doi: 10.1016/j.virol.2007.07.022. Epub 2007 Aug 28. Virology. 2007. PMID: 17727912 Free PMC article.
-
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.Cancer Res. 2006 Feb 1;66(3):1270-6. doi: 10.1158/0008-5472.CAN-05-3497. Cancer Res. 2006. PMID: 16452178
-
Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenoviruses.Methods Mol Med. 2007;130:157-68. doi: 10.1385/1-59745-166-5:157. Methods Mol Med. 2007. PMID: 17401171
-
Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds.Adv Cancer Res. 2012;115:69-92. doi: 10.1016/B978-0-12-398342-8.00003-3. Adv Cancer Res. 2012. PMID: 23021242 Review.
-
Replicating adenoviruses in cancer therapy.Curr Top Microbiol Immunol. 2004;273:291-334. doi: 10.1007/978-3-662-05599-1_9. Curr Top Microbiol Immunol. 2004. PMID: 14674605 Review.
Cited by
-
Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model.Proc Natl Acad Sci U S A. 2008 May 20;105(20):7293-7. doi: 10.1073/pnas.0800200105. Epub 2008 May 19. Proc Natl Acad Sci U S A. 2008. PMID: 18490659 Free PMC article.
-
Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.J Virol. 2009 Apr;83(8):3450-62. doi: 10.1128/JVI.02561-08. Epub 2009 Feb 4. J Virol. 2009. PMID: 19193803 Free PMC article.
-
Prospects for oral replicating adenovirus-vectored vaccines.Vaccine. 2013 Jul 11;31(32):3236-43. doi: 10.1016/j.vaccine.2013.05.016. Epub 2013 May 22. Vaccine. 2013. PMID: 23707160 Free PMC article. Review.
-
The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model.Cancer Gene Ther. 2013 Sep;20(9):531-7. doi: 10.1038/cgt.2013.50. Epub 2013 Aug 9. Cancer Gene Ther. 2013. PMID: 23928730 Free PMC article.
-
Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.Gene Ther. 2010 Dec;17(12):1430-41. doi: 10.1038/gt.2010.100. Epub 2010 Jul 22. Gene Ther. 2010. PMID: 20664541 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources